Hosted on MSN31m
Needham downgrades Biogen on slow growth of Alzheimer's drugInvesting.com - Needham downgraded Biogen Inc (NASDAQ:BIIB) on Monday, citing slower-than-expected growth for its Alzheimer's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback